Meanwhile, nine (8.5%) in the MDS, NOS with SLD group, and seven (4.8%) in the MDS, NOS with MLD group (wild type SF3B1) were diagnosed as MDS with low blasts (LB) and RS in WHO-2022 classification (Table 1). Here, SF3B1 is linked to myelodysplastic syndrome.